PREVIEW #ESMO26 — pre-conference KOL intelligence for the ESMO Congress 2026 in Madrid, Oct 23–27 See the Preview →

MajesTEC-3 Network Analysis

Picture of Brian Shields Brian Shields : Dec 15, 2025, 6:07:43 AM

 

More from KOL Pulse

More Market Than Medical — oncology KOLs Harold Burstein, David Gandara, Vinay Prasad, and Balazs Halmos on the Galleri MCED readout, FDA advisory committee September 23, 2026
“More Market Than Medical” — The Oncologists Doubting Galleri as the FDA Panel Meets
Sep 23, 2026
 Etcamah (camizestrant) FDA approved Sept 4 2026 - some KOLs agree with ODAC's no vote - SERENA-6 KOL sentiment featuring Drs. Tatiana Prowell, Hope Rugo, Sarah Sammons and Bishal Gyawali - KOL Pulse
Etcamah (Camizestrant) Is FDA Approved — and Some KOLs Still Agree With ODAC's No Vote
Sep 5, 2026
 RASONQUE: Launch Context Created by KOLs. Pancreatic cancer, RASolute 302. KOL reactions from Jun Gong, Anirban Maitra, Fernand Bteich, and Cathy Eng.
The DOL Launch: How Digital Opinion Leaders Ran Rasonque's Day One Product Launch
Aug 27, 2026